ABGESAGT: SPARK-BIH Educational Forum - Mai

Essential Regulatory Practice in the Development of Novel Therapies

Dr. Gabriele Dallmann (Biopharma Excellence Munich)

+++ Wir bedauern, Ihnen mitteilen zu müssen, dass wir aufgrund der aktuellen Situation bezüglich des Coronavirus (SARS-Cov-2) gezwungen sind, das SPARK-BIH Forum am 19. Mai abzusagen +++

Everyone is invited to join our SPARK-BIH Lecture Series taught by SPARK advisors and experts. The lectures take place ~once a month on Tuesdays from 5 to 7 pm.

For our May-Forum we are very excited to welcome Dr. Gabriele Dallmann as speaker.

Agenda

5 pm: Essential Regulatory Practice in the Development of Novel Therapies
Dr. Gabriele Dallmann (Biopharma Excellence Munich)

Networking Event with Wine & Cheese!

After the presentations, you will have time to meet the speaker and pose questions.

Registration

We look very much forward to welcoming you at our Forum - a registration is not required!

Lecture Series

We currently offer two public Lecture Series, which alternate each month:
The SPARK-BIH Educational Forum is designed to teach academic scholars the principles of Drug, Device & Diagnostic Development with focus on topics which are relevant for translational medicine.
In our SPARK-BIH Entrepreneurial Forum we recruit key opinion leaders in the fields of Business Planning & Development, Financing and Commercialization to teach entrepreneurial scientists.

SPARK-BIH is an initiative created at Stanford University, to overcome challenges associated with translation of academic discoveries.